Cinryze 500 unit vial-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FCRP7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,231
Award facts
- Contract value 100% obligated
- $62,231.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $62,231.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for CINRYZE 500 unit vials with diluents. The award, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that positions the company as one of multiple regional prime vendor contractors responsible for supplying pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with its IDC awarded on November 13, 2025, featuring a $499.9 billion ceiling value and extending through December 31, 2036. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with recent delivery orders demonstrating consistent performance across diverse therapeutic categories. As a long-standing federal contractor registered in the System for Award Management since 2001, DMS Pharmaceutical Group operates without identified subcontractors and maintains direct relationships with DLA's Medical Supply Chain division to support recurring military medical supply needs globally.
Quick answers
Who was awarded contract SPE2DR26FCRP7?
SPE2DR26FCRP7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FCRP7 worth?
The government has obligated $62,231 on SPE2DR26FCRP7.
Is contract SPE2DR26FCRP7 an order under another contract?
Yes. SPE2DR26FCRP7 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRP7 competed?
The extent of competition for SPE2DR26FCRP7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award